… For parenteral vaccine administration there are currently three routes licensed: … or needle-free
injection devices. The factors potentially impacting on the ‘performance’ of a given route of …

… Delaying drug absorption at the injection site can reduce dosing frequency, but also has
the potential to increase irritation at the injection site that could alter the immunogenicity risk …

… influence on vaccine immunogenicity and efficacy: vaccination strategy, route of vaccine …
Several studies have shown that the immunogenicity of a vaccine is lower after IM injection …

… I study for dose and injection route optimization and further assessment of the safety of the
HCV peptide … The different injection schedules, volume of injection (vaccine dosage) and …

… In order to document the immunogenicity and the safety of the vaccine when injected by
other routes, we conducted a phase II study in order to compare the immunogenicity and …

… Of these subjects, 1 subject who was assigned to 0.3-mL ID injection was excluded …
injection route. Five subjects were excluded from the 4-week postvaccination immunogenicity …

… Based upon passively collected data, we have known since the mid-1990s that the rate of
SQ injection site reactions was higher among women compared to men [16]. AVA is the only …

… alternative route to increase the immunogenicity … immunogenic and safety profiles to im
vaccination. Local reactions were more frequently reported after id vaccination, whereas injection …

… to compare the immunogenicity and safety of MM-RvaxPro and VARIVAX when both are
administered concomitantly at separate injection sites by either the SC or the IM route. …

… , which is thought to enhance the immunogenicity of influenza vaccines. There appeared
to be no correlation between injection volume or injection dose and incidence or severity of …